Bellerophon Therapeutics Inc (BLPH)
0.0551
0.00 (0.00%)
USD |
OTCM |
Apr 30, 16:00
Bellerophon Therapeutics Max Drawdown (5Y): 99.85% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 99.85% |
| March 31, 2024 | 99.85% |
| February 29, 2024 | 99.85% |
| January 31, 2024 | 99.85% |
| December 31, 2023 | 99.85% |
| November 30, 2023 | 99.84% |
| October 31, 2023 | 99.82% |
| September 30, 2023 | 98.46% |
| August 31, 2023 | 98.46% |
| July 31, 2023 | 98.46% |
| June 30, 2023 | 98.46% |
| May 31, 2023 | 98.46% |
| April 30, 2023 | 98.46% |
| March 31, 2023 | 98.46% |
| February 28, 2023 | 98.46% |
| January 31, 2023 | 98.46% |
| December 31, 2022 | 98.46% |
| November 30, 2022 | 98.07% |
| October 31, 2022 | 98.07% |
| September 30, 2022 | 98.07% |
| August 31, 2022 | 98.07% |
| July 31, 2022 | 98.07% |
| June 30, 2022 | 98.07% |
| May 31, 2022 | 98.07% |
| April 30, 2022 | 97.79% |
| Date | Value |
|---|---|
| March 31, 2022 | 97.79% |
| February 28, 2022 | 97.79% |
| January 31, 2022 | 97.79% |
| December 31, 2021 | 97.79% |
| November 30, 2021 | 97.79% |
| October 31, 2021 | 97.79% |
| September 30, 2021 | 97.79% |
| August 31, 2021 | 97.79% |
| July 31, 2021 | 97.79% |
| June 30, 2021 | 97.79% |
| May 31, 2021 | 97.79% |
| April 30, 2021 | 97.79% |
| March 31, 2021 | 97.79% |
| February 28, 2021 | 97.79% |
| January 31, 2021 | 97.79% |
| December 31, 2020 | 97.79% |
| November 30, 2020 | 97.79% |
| October 31, 2020 | 97.79% |
| September 30, 2020 | 97.79% |
| August 31, 2020 | 97.79% |
| July 31, 2020 | 97.79% |
| June 30, 2020 | 97.79% |
| May 31, 2020 | 97.79% |
| April 30, 2020 | 97.79% |
| March 31, 2020 | 97.79% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
96.08%
Minimum
May 2019
99.85%
Maximum
Dec 2023
97.99%
Average
97.79%
Median
Feb 2020
Max Drawdown (5Y) Benchmarks
| Janux Therapeutics Inc | -- |
| NovaBay Pharmaceuticals Inc | 99.91% |
| Palatin Technologies Inc | 96.46% |
| iBio Inc | 99.97% |
| Theriva Biologics Inc | 99.81% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -73.98 |
| Beta (5Y) | 0.6905 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 220.1% |
| Historical Sharpe Ratio (5Y) | -0.3011 |
| Historical Sortino (5Y) | -0.9379 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 47.56% |